@cenmag.bsky.social on Bluesky

JavaScript RequiredThis is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is. Learn more about Bluesky at bsky.social and atproto.com.

Post

C&EN (Chemical & Engineering News)

cenmag.bsky.social

did:plc:u4u4yeik2uube2g6ov7wr35p

Aizen Therapeutics launches to develop mirror peptides Mirror peptide–based biologics could be stabler than traditional peptide-based drugs: https://cen.acs.org/pharmaceuticals/drug-discovery/Aizen-Therapeutics-launches-develop-mirror/102/web/2024/11?sc=241202_sc_eng_blue_cen

2024-12-02T18:14:18.965Z